| Patents for A61K 49 - Preparations for testing in vivo (35,376) |
|---|
| 07/26/2007 | US20070173446 Administering porcine B-domainless factor VIII (OBI-1) to patient having factor VIII deficiency using recombinant B-domainless porcine fVIII, which has greater bioavailability compared to the natural porcine fVIII partially purified from porcine plasma, termed HYATE:C; hemophilia treatment |
| 07/26/2007 | US20070173436 Compositions and methods for enhancing drug delivery across and into epithelial tissues |
| 07/26/2007 | US20070172920 Immunoconjugates and humanized antibodies specific for b-cell lymphoma and leukemia cells |
| 07/26/2007 | US20070172428 Multivalent constructs for therapeutic and diagnostic applications |
| 07/26/2007 | US20070172427 Biofunctionalized quantum dots for biological imaging |
| 07/26/2007 | US20070172426 Polymer coated microparticles |
| 07/26/2007 | US20070172425 Testing cell cycle regulation effect of a compound using a hollow fibre cell implant |
| 07/26/2007 | US20070172424 Enabling drug adherence through closed loop monitoring & communication |
| 07/26/2007 | CA2639920A1 Test method for assessing irritation of skin |
| 07/26/2007 | CA2636990A1 Animal model for assessing copd-related diseases |
| 07/26/2007 | CA2635691A1 Combination therapy with parp inhibitors |
| 07/25/2007 | EP1811296A1 Methods and apparatus for measuring skin surface condition |
| 07/25/2007 | EP1810688A1 Pharmaceutical preparation containing coated magnetic particles and method for production thereof, and diagnosis therapy system |
| 07/25/2007 | EP1809351A2 Container with constrained quality maintenance agent |
| 07/25/2007 | EP1809341A2 Truncated fragments of alpha-synuclein in lewy body disease |
| 07/25/2007 | EP1809340A2 Stoichiometrically defined dye-labeled substances for measuring glomerular filtration rate, the production thereof and their use |
| 07/25/2007 | EP1809339A2 Compounds, kits and methods for use in medical imaging |
| 07/25/2007 | EP1809338A1 Method for continuous visualization of a blood clot or plaque in a body lumen |
| 07/25/2007 | EP1534346A4 Toluidine blue o drug substance and use thereof for in vivo staining and chemotherapeutic treatment of dysplastic tissues |
| 07/25/2007 | EP1444236B1 Separation of regioisomers of metal phthalocyanines |
| 07/25/2007 | EP1073475B1 Improvements in or relating to diagnostic/therapeutic agents |
| 07/25/2007 | CN101005858A Gas-filled microvesicles composition for contrast imaging |
| 07/25/2007 | CN101003800A Cloning using donor nuclei from non-serum starved, differentiated cells |
| 07/25/2007 | CN101003387A Method for preparing magnetic Nano composite granules coated by polyelectrolyte of positive ions |
| 07/25/2007 | CN101002952A Contrast medium for gastrointestinal tract |
| 07/25/2007 | CN101002951A Superparamagnetism magnetic resonance contrast medium, and its preparing method |
| 07/25/2007 | CN101002950A Magnetic resonace imaging contrast medium with glycyrrhizic acid as carrier |
| 07/25/2007 | CN101002949A HIV-Env gene DNA allosterism recombination envelope protein antigen for immunoresponsiveness of anti-HIV test and method |
| 07/25/2007 | CA2575649A1 Lanthanide rich nanoparticles, and their investigative uses in mri and related technologies |
| 07/24/2007 | US7248908 Method for measuring the concentration of a substance in a living body and device for measuring the same concentration |
| 07/24/2007 | US7247782 Genetic music |
| 07/24/2007 | US7247655 Such as methyl-5-aminolevulinate hydrochloride; porphyrins; antitumor agents; anticancer agents |
| 07/24/2007 | US7247641 Compounds, derivatives, compositions, preparation and uses |
| 07/24/2007 | US7247501 Imaging and targeting tumors using sickle cells |
| 07/24/2007 | US7247302 Method for inhibiting immunoglobulin-induced toxicity resulting from the use of immunoglobulins in therapy and in vivo diagnosis |
| 07/24/2007 | CA2110491C Gas filled liposomes and their use as ultrasonic contrast agents |
| 07/19/2007 | WO2007082048A2 Ex vivo hyperpolarization of imaging agents |
| 07/19/2007 | WO2007081516A2 Tumor activated prodrugs |
| 07/19/2007 | WO2007049264A3 Assays using nanoparticles |
| 07/19/2007 | WO2005033661A3 Dmbt1 as a clinical marker and uses thereof |
| 07/19/2007 | US20070166276 Useful in extending the in vivo circulating life of biologically active materials; bicine linker allows for the manipulation of the hydrolysis rate of the prodrug, thereby releasing the native entities at various rates in vivo as well as in vitro |
| 07/19/2007 | US20070166232 Magnetic nanoparticles |
| 07/19/2007 | US20070166231 Methods and probes for identifying vulnerable plaque |
| 07/19/2007 | US20070166230 Ion channel |
| 07/19/2007 | US20070166229 Cardiovascular safety assay |
| 07/19/2007 | US20070166228 Neutral labeling reactants and conjugates derived thereof |
| 07/19/2007 | DE102006058424A1 Quantifizierung von Probeneigenschaften unter Nutzung von Kontrastverstärkung bei Sättigungstransfer Quantification of sample properties with the use of contrast enhancement in saturation transfer |
| 07/19/2007 | CA2630432A1 Novel gene disruptions, compositions and methods relating thereto |
| 07/18/2007 | EP1808071A1 Construction of arterial occlusive disease animal model |
| 07/18/2007 | EP1807146A2 Composition for improving efficiency of drug delivery |
| 07/18/2007 | EP1807119A2 Pet and magnetic resonance for screening alzheimer's disease therapeutics |
| 07/18/2007 | EP1807118A2 Steroid analogs and characterization and treatment methods |
| 07/18/2007 | EP1807115A1 Nanoparticles comprising an intracellular targeting element and preparation and use thereof |
| 07/18/2007 | EP1513450A4 Method of preparing gas-filled polymer matrix microparticles useful for echographic imaging |
| 07/18/2007 | CN1327226C Saliva pretreatment reagent box and saliva pretreatment process |
| 07/18/2007 | CN1326570C Parmagnetic nanoparticle |
| 07/18/2007 | CN101001609A Method of manufacturing pharmaceutical preparations containing liposomes |
| 07/18/2007 | CN100998875A Acetic acid white detection sticking strip |
| 07/18/2007 | CN100998601A Medicine for treating diabete type-2 and its estimation model |
| 07/17/2007 | US7246012 Characterizing biological stimuli by response curves |
| 07/17/2007 | US7244832 host cell tranformed with a nucleic acid encoding an antibody having a composite heavy chain with a variable domain including complementarity determining regions and framework regions comprising human acceptor antibody heavy chain framework region residues |
| 07/17/2007 | US7244615 Producing an antibody comprising complementarity determining regions, heavy and light chains, and non-human donor residues, a variable domain; used for in vivo therapy and diagnosis |
| 07/17/2007 | US7244412 Methods for manipulating upper gastrointestinal transit, blood flow, and satiety, and for treating visceral hyperalgesia |
| 07/17/2007 | US7244410 Low density lipoprotein binding proteins and their use in diagnosing and treating atherosclerosis |
| 07/17/2007 | US7244232 Feeding a stream of cells, to a reservoir containing markers; labeling the cells, feeding the labeled cells to a particle analyzer using a stent and detecting the cancerous cells |
| 07/17/2007 | CA2170879C Diagnostic uses of hydrazinoadenosines |
| 07/12/2007 | WO2007077990A1 Drug delivery material |
| 07/12/2007 | WO2007076848A2 Diagnostic substance and method for the analysis of metabolism processes in the brain |
| 07/12/2007 | WO2007042833A3 Arnphiphilic nanotubes and micelles comprising same for use in the delivery of biologically active agents |
| 07/12/2007 | WO2007006041A8 Imaging and therapeutic method using monocytes |
| 07/12/2007 | WO2007002009A3 Product authentication |
| 07/12/2007 | WO2006090259A3 A method for screening photosensitive compound |
| 07/12/2007 | WO2006065987A3 Systems and methods of light-scattering based in vivo flow cytometry |
| 07/12/2007 | WO2003077723A3 Methods and devices for detection and therapy of atheromatous plaque |
| 07/12/2007 | US20070162985 measuring an increase in protein expression in blood, urine or cerebrospinal fluid samples, for the diagnosis of diabetes |
| 07/12/2007 | US20070161072 Neuroprotection by inhibition of diacyglycerol kinase epsilon activity |
| 07/12/2007 | US20070160539 HPRP4s Modifiers of the p53 Pathway and Methods of Use |
| 07/12/2007 | US20070160538 Antianxiety drugs and a method of screening the same |
| 07/12/2007 | US20070160537 In vivo screening method of therapeutic agent for memory/learning dysfunctions by schizophrenia |
| 07/12/2007 | US20070160536 prodrug comprising 8-O-(12[L-leucinoylamino]dodecanoyl)-8-O-debutanoylthapsigargin (L12ADT); and a peptide of sequence Ser-Ser-Lys-Tyr-Gln; peptide is linked to the L12ADT to inhibit the therapeutic activity of the drug; anticarcinogenic agent; benign prostate hyperplasia; prostate and breast cancer |
| 07/12/2007 | US20070160534 Conjugate comprising a peptide having an engineered amino acid sequence capable of binding a plasma protein, said peptide conjugated to the therapeutic or diagnostic substance, wherein elimination half time of conjugate exceeds that of unconjugated therapeutic or diagnostic substance; peptide ligands |
| 07/12/2007 | US20070160532 Composition for medical use having improved water-solubility of peptide and metal-labeling efficiency and preparation for medical use comprising metal-labeled peptide |
| 07/12/2007 | US20070160531 Targeting endothelium for tissue-specific delivery of agents |
| 07/12/2007 | US20070160526 Detection, monitoring and treatment of cancer |
| 07/11/2007 | EP1806585A1 Detection, monitoring and treatment of cancer |
| 07/11/2007 | EP1806350A2 Amphipatic polycarboxylic chelates and complexes with paramagnetic metals as MRI contrast agents |
| 07/11/2007 | EP1805186A2 Radicals and their use as paramagnetic agents in a dynamic nuclear polarisation process |
| 07/11/2007 | EP1594550A4 Chelating agents with lipophilic carriers |
| 07/11/2007 | EP1388013B1 Compositions and methods for the use of fibronectin fragments in the diagnosis of cancer |
| 07/11/2007 | CN1997741A Novel mite allergen |
| 07/11/2007 | CN1997399A Polymer conjugate releasable under mild thiolytic conditions |
| 07/11/2007 | CN1997382A Bispecific binding agents for modulating biological activity |
| 07/11/2007 | CN1997377A Novel 2'-C methyl nucleoside derivatives |
| 07/11/2007 | CN1994472A Method for preparing nanosphere of gadopentetate dimeglumine |
| 07/11/2007 | CN1994471A Animal model using immunosuppressant chicken for testing drug immunity enhancing function |
| 07/11/2007 | CN1325638C Production of mouse model of viral hepatitis B with high expression HBsAg |
| 07/11/2007 | CN1325119C CT blood bath contrast medium and its preparation method |
| 07/10/2007 | US7241877 Humanised antibodies |
| 07/10/2007 | US7241736 spider, silkworm or other silk as a fibrosing agent; induce adhesion or fibrosis in the walls of the diverticula or facilitate "filling" of the diverticula in situ; thus obliterating the lumen of the diverticula and relieving symptoms |
| 07/10/2007 | US7241733 Mammalian EPO mimetic CH1 deleted mimetibodies, compositions, methods and uses |